Drug maker GSK invests in gene profiling services
Jul 25, 2018
Drug maker GlaxoSmithKline says second-quarter revenue totaled 7.3 billion pounds ($9.6 billion), a 4 percent increase at constant currency exchange rates, amid promising performances for vaccines and a new shingles treatment